Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Oncology (Williston Park). 2014 Oct;28(10):867–878.

TABLE 3.

Variant 3: Initial treatment of a 60-year-old female without significant past medical history, with uT3N0 rectal cancer, bilobar hepatic metastases (50% liver replacement), and bilateral pulmonary metastases. Rectal lesion causing pain and early symptoms of obstruction. KPS 80

Treatment Rating* Comments

Initial preoperative pelvic RT + concurrent 5-FU based chemotherapy 7
Initial systemic 5-FU-based chemotherapy (FOLFOX/FOLFIRI) 6 Consider anti-EGFR agents with FOLFOX/FOLFIRI in wild-type KRAS tumors
Initial palliative stent or loop colostomy to relieve obstruction 5
Initial systemic 5-FU-based chemotherapy (FOLFOX/FOLFIRI + bevacizumab) 4
Initial resection of rectal primary 3
Initial pelvic RT alone 2
Initial surgical debulking of metastatic disease 1
Initial liver directed therapies (transarterial embolization, radiation, RFA) 1
Best supportive care 1
*

Rating scale: 1–3, usually not appropriate; 4–6, may be appropriate; 7–9, usually appropriate.